Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PFE
PFE logo

PFE

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PFE News

Innovent and Pfizer Enter Strategic Collaboration for Cancer Medicines

1d agoNewsfilter

EMA Recommends Targeting XFG Variant for 2026/2027 Vaccines

15h agoseekingalpha

Regulatory Approvals and Collaborations in Biotech Sector

16h agoNASDAQ.COM

FDA Proposes Reducing Animal Studies for Cancer Drugs

17h agoseekingalpha

Valuation Analysis of U.S. Stocks: Pfizer and Others Undervalued

17h agoseekingalpha

Pfizer's LORBRENA Shows Significant Efficacy Improvement

18h agoNASDAQ.COM

FDA Panel Recommends Updating COVID Vaccines for XFG Variant

22h agoseekingalpha

Pfizer Enters Strategic Licensing Agreement with Innovent for Cancer Drug Development

22h agoNASDAQ.COM

Pfizer and Innovent Biologics Form $10.5B Oncology Partnership

1d agoseekingalpha

Pfizer and Innovent Enter Strategic Collaboration for Cancer Medicines

1d agoNewsfilter

Innovent Biologics Partners with Pfizer for Oncology Drug Development

1d agoCNBC

Innovent and Pfizer Enter Strategic Collaboration for Cancer Medicines

1d agoPRnewswire

FDA Advisory Panel to Vote on COVID Vaccine Target Variant

1d agoNewsfilter

Pfizer to Host Investor Webcast at Jefferies Conference

2d agoNewsfilter

FDA Advisory Panel to Discuss 2026-2027 COVID Vaccine Composition

3d agoseekingalpha

BridgeBio Pharma Shares Drop After Downgrade by Raymond James

3d agoseekingalpha